BackgroundAntimicrobial resistance, which is commonly observed in the management of pneumonia, is a major threat to public health and is driven by inappropriate antimicrobial use. The aim of this study was therefore to assess the current practice of antimicrobial utilization and clinical outcomes in the management of adult pneumonia at Tikur Anbessa Specialized Hospital. and patients aged � 14 years and diagnosed with pneumonia were included. Chart review and self-administered questionnaire were used to collect data regarding pneumonia diagnosis and management as well as clinical outcomes (stable, complications, and in-hospital mortality). Descriptive statistics and binary logistic regressions were performed for data analyses.
Introduction the World Health Organization has identified vaccine hesitancy as one of the top ten threats to global health. The purpose of this study was to explore factors contributing to COVID-19 vaccine hesitancy among healthcare providers, their perspectives regarding vaccine uptake by the public and their recommendations to improve vaccine uptake in Ethiopia. Methods a phenomenological qualitative study was conducted among purposively selected healthcare providers working in the Ministry of Health (MoH), regulatory authority, public and private hospitals and health centres who hesitated to take the COVID-19 vaccine in Addis Ababa, Ethiopia in June 2021. A total of twenty in-depth interviews were conducted using a semi-structured open-ended interview guide. Participants included nurses, physicians, pharmacists, health officers, Medical Laboratory technologists and midwives. A qualitative content analysis approach was chosen to analyse the data. Results all the participants agreed (n=20) that lack of consistent information and inadequate evidence about COVID-19 vaccine safety, efficacy and quality were the main reasons for COVID-19 vaccine hesitancy. History of perceived and confirmed COVID-19 infection history, misinformation, religious views, unknown short and long-term effects of the vaccine and undefined length of time of vaccine´s protection were also other reasons mentioned by the participants. Conclusion healthcare providers were hesitant toward COVID-19 vaccine mainly due to lack of clear evidence regarding the vaccine´s short and long-term safety, efficacy and quality profiles. Hence, the long-term safety and efficacy of the vaccine should be extensively studied and evidence dissemination and communication should be clear and transparent.
Background: Antimicrobial resistance is a major threat to public health and is driven by inappropriate antimicrobial use, which is commonly observed in the management of pneumonia. The aim of this study was therefore to assess the current practice of antimicrobial utilization and clinical outcomes in the management of adult pneumonia patients attending at Tikur Anbessa Specialized Hospital.Methods and materials: Method: A prospective observational study was conducted in a 95-bed internal medicine ward of Tikur Anbessa Specialized Hospital. Patients aged ≥14 years, with physicians' diagnosed with pneumonia were included in the study, conducted from 1 September 2016 to 30 June 2017. Chart review and self-administered questionnaires were used to collect data. Descriptive statistics and binary logistic regressions were performed for data analyses.Results: Out of 200 enrolled patients, clinical diagnosis was supported by microbiologic testing and imaging in75 (37.5%) and 122 (61.0%) cases, respectively. The treatment approach in almost all patients (99.5%) was empirical. No de-escalation therapy was made even after acquiring culture results. Vancomycin was the most commonly prescribed antimicrobial agent (25%) and about 70% of the patients had received this drug empirically. The total duration of antimicrobial therapy was 12.05 ± 5.09 days. About 30% of the patients missed their antimicrobial doses during the course of treatment and stock-outs were the major reason (36.7%). Close to 113 (66%) of the treating physicians used reference books to prescribe antimicrobial agents. Two-third (66%, 133) of the patients were stable. In-hospital mortality and complications accounted for 18.5% (37) and 17% (34), respectively. Poor clinical outcome (death and complicated cases)was found to be associated with recent antimicrobial use history (p = 0.007, AOR 2.86 (1.33-6.13)), cancer (p = 0.023, AOR 3.46 (1.18-10.13)), recent recurrent upper respiratory tract infection (p = 0.046, AOR 3.70 (1.02-13.40)), respiratory rate >24breaths/min or <12breaths/min (p = 0.013, AOR 2. 45 (1.21-4.95)) and high level of serum creatinine after initiation of antimicrobial therapy (>1.4 mg/dl) (p = 0.032, AOR 2.37 (1.07-5.20)).Conclusion: Antimicrobials are empirically prescribed without sufficient evidence of indication and microbiological or radiological findings. Besides, the practice is not based on local guidelines and no multidisciplinary approach is apparent. As a result, there were higher rates of mortality (18.5%) when compared with other similar studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.